Human immunodeficiency virus (HIV) load is suppressed during dengue virus infection. The NS5A phosphoprotein of GB virus C (a related flavivirus) inhibits HIV replication in vitro. To determine whether the dengue virus NS5 protein inhibits HIV replication, CD4 ؉ T cell lines expressing this protein were generated. HIV replication in dengue virus NS5-expressing cells decreased by >90% compared with control cells (P<.01), and this was mediated in part by decreased HIV coreceptor (CXCR4) expression and increased production of SDF-1. Thus, the dengue virus NS5 protein inhibits HIV replication in vitro, potentially explaining the reduction in HIV load observed during acute dengue virus infection.
Human immunodeficiency virus (HIV) load is suppressed during dengue virus infection. The NS5A phosphoprotein of GB virus C (a related flavivirus) inhibits HIV replication in vitro. To determine whether the dengue virus NS5 protein inhibits HIV replication, CD4 ؉ T cell lines expressing this protein were generated. HIV replication in dengue virus NS5-expressing cells decreased by >90% compared with control cells (P<.01), and this was mediated in part by decreased HIV coreceptor (CXCR4) expression and increased production of SDF-1. Thus, the dengue virus NS5 protein inhibits HIV replication in vitro, potentially explaining the reduction in HIV load observed during acute dengue virus infection.
In HIV-infected individuals, plasma HIV RNA levels typically increase during intercurrent infections [1] . However, Watt et al. [2] reported that acute dengue virus (DENV) infection of an HIV-infected patient was associated with suppression of HIV RNA. Specifically, the patient's HIV RNA load was Ͻ2.87 log 10 copies/mL (i.e., Ͻ750 copies/mL) when he presented to the hospital with acute DENV infection, which increased to approximately 3.25, 4.5, and 4.6 log 10 copies/mL 3, 14, and 28 days, respectively, following admission, suggesting that DENV infection inhibited HIV replication [2] . Serum obtained from the patient on the day of admission inhibited HIV replication in vitro when added to lymphocytes, whereas neither control serum nor a convalescent-phase serum specimen obtained from the patient 14 days after admission inhibited HIV replication.
Thus, DENV infection appeared to induce soluble factor(s) that inhibited HIV replication [2] .
DENV causes a mosquito-borne disease in tropical areas that is estimated to result in 100 million cases of dengue fever annually [3] . The virus contains a single-stranded, positive-sense RNA genome and is a member of the family Flaviviridae [4] . A related flavivirus, GB virus type C (GBV-C), replicates in CD4 ϩ T cells and inhibits HIV replication in cell culture systems [5, 6] , and the mechanisms by which GBV-C inhibits HIV have been partially elucidated. GBV-C replication in peripheral blood mononuclear cells (PBMCs) decreases the surface expression of the HIV coreceptors (chemokine receptors CCR5 and CXCR4) on CD4 ϩ T cells and increases the production of various chemokines that serve as competitive inhibitors of HIV for the HIV coreceptors [5, 6] . Expression of the GBV-C nonstructural phosphoprotein (NS5A) in a CD4 ϩ T cell line potently inhibits HIV replication, and this effect is also mediated at least in part by down-regulation of CXCR4 and induction of SDF-1 [7] .
The overall genome structure of DENV is similar to that of GBV-C, with some notable exceptions. The DENV NS5 phosphoprotein is not processed into 2 polypeptides (NS5A and NS5B) and thus is much larger than the GBV-C NS5A protein (898 vs. 414 amino acids) [7] . The amino terminal portion of DENV NS5 has methyl transferase activity, mediating 5' capping of the viral genome for translation [4] , whereas GBV-C uses an internal ribosomal entry site (IRES) to direct translation of the viral polyprotein. Although the amino acid sequences of DENV NS5 and GBV-C NS5A are Ͻ15% identical, both DENV NS5 and GBV-C NS5A have amphipathic amino acid sequences at their amino termini that anchor the protein in the endoplasmic reticulum membrane, and both proteins are phosphorylated [4, 8] . The RNA-dependent RNA polymerase activity is part of the DENV NS5 protein, whereas this function is retained in the GBV-C NS5B protein. We stably expressed the DENV NS5 protein in a CD4 ϩ T cell line (Jurkat) to determine whether this protein, like the related GBV-C NS5A protein, interferes with HIV replication.
Materials and methods. A plasmid containing the fulllength DENV (serotype 2) NS5 protein was kindly provided by Dr. Alan Rothman (University of Massachusetts) [9] . The DENV NS5 coding sequence was subcloned into a pTRE2-Hgy plasmid (Clontech) modified to include a Kozak sequence at the initiation codon, a stop codon after NS5, followed by the encephalomyocarditis virus IRES element directing the translation of green fluorescent protein (GFP) and a polyadenylation signal as previously described [7] . Sequences were confirmed by automated fluorescent dye terminator cycle sequencing performed at the University of Iowa DNA Core Facility (automated DNA sequencer 373A [Applied Biosystems]). Tet-Off Jurkat cells (Clontech) were transfected (Amaxa nucleofectin [Amaxa]) with plasmids containing either DENV NS5 sequences, the vector control sequences including GFP, or a frameshift mutation in GBV-C NS5A sequences as previously described [7] . After selection in hygromycin and neomycin (200 g/mL of each), clonal cell lines were prepared by at least 2 rounds of terminal dilution cloning. Cells were maintained in RPMI 1640 with 10% fetal calf serum containing hygromycin and neomycin. DNA sequence alignments and predicted protein secondary structure analyses used DNAMan software (Lynnen Biosoft).
An HIV-1 isolate (X4) representing clade B [10] was applied to CD4 ϩ T cell lines (Jurkat) expressing DENV NS5 protein or the vector control (200 pg of HIV p24 antigen per 10 6 cells). Following a 3-h attachment period, the cells were washed and maintained in fresh media. Culture supernatants were obtained at various time points to measure HIV-1 replication. All infections were performed in triplicate, and experiments were repeated at least 3 times with similar results. HIV-1 replication was determined by measuring the level of HIV p24 antigen in culture supernatants (Retro-Tek HIV-1 p24 antigen ELISA kits [Zeptometrix]) [7] .
CXCR4 and CCR5 expression on the surface of Jurkat cells was determined by flow cytometry as previously described [5] .
Figure 1. Dengue virus (DENV) (serotype 2) NS5 protein expression in a CD4
ϩ T cell line inhibits HIV replication. The coding sequence for the entire DENV NS5 protein was inserted into a plasmid in which translational stop codons were placed at the C-terminus of the protein. This was followed by the encephalomyocarditis virus internal ribosomal entry site (IRES), which drives translation of green fluorescent protein (GFP) (A). Cell lines that expressed GFP were selected and cloned (B), and cellular DNA and RNA was extracted. DNA and RNA were amplified by PCR and RT-PCR, respectively, and NS5 sequences were intact for the DENV NS5 cell line, whereas a DENV-negative control cell line (DV-NC) contained the encephalomyocarditis virus IRES and GFP sequences but not the upstream DENV NS5 sequences. HIV replication was inhibited in the DENV NS5 cell line (C) but not the DV-NC cell line or the cell line expressing the plasmid vector control (VC). In addition, HIV was not inhibited in a cell line containing a GB virus type C NS5A coding region in which a frameshift mutation was inserted (FS) as described in the Results section ( C). HIV p24 antigen (Ag) levels were significantly lower than those for controls on days 4 -7 (P Ͻ .01 for all dates). All experiments were performed in triplicate and repeated at least 3 times with similar results.
Polyclonal rabbit anti-CCR5 (FITC-conjugated) and anti-CXCR4 (PE-conjugated) antibodies (BD Pharmingen) were used in these studies. Flow cytometry was performed using a FACScan (Becton Dickenson). SDF-1, RANTES, MIP-1␣, and MIP-1␤ were detected in culture supernatant fluids by ELISA (R&D Systems) as previously described [5] . Determinations were made in triplicate and repeated at least once.
Statistical analyses were performed using SigmaStat, version 3.11 (Jandel Scientific). Comparisons of 2 samples were conducted using t tests, and comparisons of Ͼ3 samples were performed by analysis of variance.
Results. The DENV NS5 protein was expressed in CD4 ϩ T cells, using the bicistronic expression plasmid shown in figure  1A and previously described for GBV-C [7] . A Kozak sequence was inserted immediately upstream of the DENV NS5 coding sequence, and stop codons in all 3 reading frames were inserted at the end of NS5, followed by the encephalomyocarditis virus IRES element that drives translation of the second open reading frame (GFP) and a polyadenylation site. Because no DENV anti-NS5 antibodies were available to identify protein in these cells, 3 methods were used to confirm expression. First, clonally selected cell lines were identified that expressed GFP (figure 1B). Consistent with previous studies, the level of expression of the upstream reading frame altered the translation efficiency of the downstream open reading frame, in this case GFP [11] . Second, cellular DNA was extracted and NS5 sequences amplified using PCR primers upstream of the CMV promoter region and within the GFP coding region, and the product including the entire DENV NS5 coding region was sequenced. In the cell line designated DENV, sequence analysis demonstrated that the linkages of NS5 sequences to the IRES and GFP sequences were intact. In addition, GFP was expressed. In contrast, another clonal cell line had a large deletion in the NS5 sequence, although the CMV promoter and the IRES and GFP sequences were present (data not shown); this cell line was used as a negative control. Third, total cellular RNA was extracted from DENV cells and amplified by RT-PCR, and NS5 products were cloned into pCR 2.1. Sequencing analysis confirmed the presence of the NS5 mRNA in this cell line. The template was RNA because no DENV sequences were amplified when reverse transcriptase was not included in the buffer (data not shown). Two additional control cell lines were studied, one containing only the vector with GFP, and another containing GBV-C NS5A sequences in which a frameshift mutation was introduced [7] . This cell line includes GBV-C NS5A DNA, but does not express GBV-C NS5A protein.
HIV replication was significantly diminished in the cells expressing the DENV NS5 protein, and release of HIV p24 antigen into culture supernatants was reduced by Ͼ95% three to seven days after infection, compared with the 3 control cell lines (P Ͻ .001 on all 4 days studied) ( figure 1C) . The functional region of GBV-C NS5A that is sufficient to inhibit HIV replication when expressed in Jurkat cells was mapped to an 85-amino acid fragment (GBV-C amino acids 152-236) [7] . Alignment of this 85-amino acid sequence with that of DENV NS5 did not identify any regions that shared Ͼ15% sequence homology; thus, the functional similarities can not be explained by sequence homology.
In cells expressing the GBV-C NS5A protein, the HIV entry coreceptor (CXCR4) is down-regulated [7] . Jurkat cells expressing the DENV NS5 protein also down-regulated CXCR4 expression, compared with expression by the vector control cells, as determined by flow cytometry (P ϭ .03; figure 2A ). Because CCR5 was not expressed on the surface of Jurkat cells, this HIV coreceptor could not be assessed (data not shown). DENV NS5 protein also induced the release of SDF-1, the ligand for CXCR4 and a known competitive inhibitor of HIV-1 entry. Significantly more SDF-1 was released into cell culture supernatants in the DENV NS5-expressing cells on days 1-7 (P Ͻ .05 for all) (figure 2B) . The concentration of SDF-1 released into culture supernatants has previously been shown to inhibit HIV replication [5]. RANTES, MIP-1a, or MIP-1b were not detected in any of the Jurkat cell culture supernatants.
Discussion. Many human hosts with HIV infection are simultaneously infected with multiple pathogenic and nonpathogenic microbes. Interactions between these coinfecting agents and HIV are likely to occur, and acute DENV infection [2] , measles virus [12] , and scrub typhus [13] are associated with a transient reduction in HIV load. Measles, dengue fever, and scrub typhus are self-limited infections and are unlikely to have an impact on the overall natural history of HIV infection. In contrast, GBV-C infection results in persistent infection in many individuals, and persistent GBV-C infection is associated with prolonged survival in HIV-infected people [14] . Measles and GBV-C infection of CD4 ϩ T cells in vitro also result in inhibition of HIV replication at an early step in HIV replication [15] , providing plausible biological support of a causal relationship between the infections and a beneficial clinical outcome. DENV causes an arthropod-borne disease transmitted by the Aedes aegypti mosquito (and on rare occasion by Aedes albopictus), and the virus causes considerable morbidity and mortality worldwide [3] . In naturally infected hosts, DENV antigen is found in cells of the monocyte-macrophage lineage within lymphoid organs and also in lung, liver, and PBMCs [3] and can replicate in a variety of cultured cells in vitro, including human lymphocytes [16] . Acute DENV infection was associated with suppression of HIV load, and the fact that acute serum inhibited HIV replication in vitro suggested that soluble factors inhibiting HIV were elicited [2] . No prior study has examined interactions between DENV replication or protein expression and HIV. In this study, we demonstrated that expression of serotype 2 DENV NS5 protein down-regulated CXCR4, induced SDF-1, and potently inhibited HIV replication in vitro, similar to the effects observed when the NS5A protein from a related flavivirus (GBV-C) was expressed in Jurkat cells [7] . In contrast to GBV-C, DENV infection is self-limited and is unlikely to be a long-term factor in HIV natural history or disease progression.
In GBV-C, an 85-amino acid fragment of NS5A (amino acids 152-236) is sufficient for HIV inhibition and modulation of CXCR4 and SDF-1 [7] . Sequence alignment of the DENV NS5 protein with this GBV-C fragment failed to identify a homologous region in DENV, suggesting that either there is a structural mimetic within the protein or the mechanism is the result of an RNA interaction within the cell. This is unlikely because cell lines containing GBV-C sequences with a frameshift that contained the viral RNA sequences but not the NS5A protein did not inhibit HIV replication [7] . Thus, it appears that the HIV inhibition mediated by the DENV NS5 protein results from intracellular protein-protein interactions that lead to modification of cellular susceptibility to HIV infection [7] .
The finding that the NS5 phosphoprotein from 2 distinct viruses within the same family (Flaviviridae) down-regulates CXCR4 and induces the release of SDF-1 suggests that this protein is involved in immune evasion and/or replication. Further studies with additional viruses in the Flaviviridae family are underway to better characterize these virus-host cell relationships. In conclusion, the in vitro interaction between the DENV NS5 protein and HIV replication may be involved in the prior clinical observation that HIV load is suppressed during acute DENV infection [2] .
